Cost effectiveness analysis of erythropoietin therapy in the ministry of health dialysis programme
End-stage renal failure patients are normally anaemic due to failure of renal to produce endogenous erythropoietin (EPO). Erythropoietin is used to treat anaemia in these patients but the drug is expensive. The drug is also used in cancer and thalassemia patients and it makes EPO in high demand and...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 語言: | English |
| 出版: |
2006
|
| 主題: | |
| 在線閱讀: | http://eprints.usm.my/51024/1/Cost%20effectiveness%20analysis%20of%20erythropoietin%20therapy%20in%20the%20ministry%20of%20health%20dialysis%20programme24.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|